Company news
IXICO PLC news in 2021
IXICO PLC's news releases, calls and decks from 2021, newest first.
Financial Results for the year ended 30 Sept 2021
December 7, 2021
Notice of Results
November 22, 2021
New contract worth >£1.0m
November 1, 2021
Contract update
October 20, 2021
Trading Update for year ended 30 September 2021
October 18, 2021
New contract worth >$750k
September 22, 2021
Phase II HD contract with new client worth >$500K
September 20, 2021
Phase I MSA contract award worth >$500k
September 8, 2021
Issue of Equity
June 23, 2021
Half yearly report to 31 March 2021
May 25, 2021
Phase II Alzheimer's disease contract award
May 20, 2021
Contract win for new neuroinflammatory disorder
May 19, 2021
Notice of results
May 11, 2021
Contract win for new stroke study
April 28, 2021
Trading update
April 26, 2021
PDMR Transaction
March 25, 2021
Huntington's disease Phase III contract updates
March 23, 2021
Collaboration with Microsoft
March 15, 2021
IXICO chosen for new Phase II AD study
March 10, 2021
IXICO selected by Cyclerion for a new AD study
March 2, 2021
Exercise of Options; PDMR Dealing
March 1, 2021
Conference attendance and presentations
March 1, 2021
PDMR Dealing
January 29, 2021